Closed-loop automated oxygen control in ventilated infants born at or near term: A crossover trial

Acta Paediatr. 2023 Feb;112(2):246-251. doi: 10.1111/apa.16598. Epub 2022 Nov 27.

Abstract

Aim: To determine if the use of closed-loop automated oxygen control (CLAC) reduced the incidence and duration of hypoxemic episodes (SpO2 < 92%) in ventilated infants born at or above 34 weeks of gestation.

Methods: Infants were studied on two consecutive days for 6 h each day. They were randomised to receive standard care (manual oxygen control) or standard care with a CLAC system (automated oxygen control) first.

Results: Sixteen infants with a median (IQR) gestational age of 37.4 (36.6-38.8) weeks were studied at a median (IQR) postmenstrual age of 38.8 (37.4-39.8) weeks. During the automated oxygen control period, infants spent less time in hypoxemia (SpO2 < 92%) (p = 0.033), episodes of desaturation were shorter (p = 0.001), the time spent within target SpO2 range (92%-96%) was increased (p = 0.001), and the FiO2 delivery was lower (p = 0.018). The time spent in hyperoxemia (SpO2 > 96%) was reduced during automated oxygen control (p = 0.011), the episodes of hyperoxemia were of shorter duration (p = 0.008) and fewer manual adjustments were made to the FiO2 (p = 0.005).

Conclusions: Closed-loop automated oxygen control in ventilated infants born at or near term was associated with a reduction in the incidence and duration of hypoxemic episodes with more time spent in the target oxygen range.

Keywords: closed-loop automated oxygen delivery; hyperoxemia; hypoxemia; term infant.

MeSH terms

  • Cross-Over Studies
  • Humans
  • Hypoxia / prevention & control
  • Infant
  • Infant, Newborn
  • Infant, Premature*
  • Oximetry
  • Oxygen Inhalation Therapy
  • Oxygen*
  • Respiration, Artificial

Substances

  • Oxygen